EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors

od Zander, Serge A. L., Sol, Wendy, Greenberger, Lee, Zhang, Yixian, van Tellingen, Olaf, Jonkers, Jos, Borst, Piet, Rottenberg, Sven
Wydane 2012

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

od Rottenberg, Sven, Jaspers, Janneke E., Kersbergen, Ariena, van der Burg, Eline, Nygren, Anders O. H., Zander, Serge A. L., Derksen, Patrick W. B., de Bruin, Michiel, Zevenhoven, John, Lau, Alan, Boulter, Robert, Cranston, Aaron, O'Connor, Mark J., Martin, Niall M. B., Borst, Piet, Jonkers, Jos
Wydane 2008

Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors

od Rottenberg, Sven, Vollebergh, Marieke A., de Hoon, Bas, de Ronde, Jorma, Schouten, Philip C., Kersbergen, Ariena, Zander, Serge A.L., Pajic, Marina, Jaspers, Janneke E., Jonkers, Martijn, Lodén, Martin, Sol, Wendy, van der Burg, Eline, Wesseling, Jelle, Gillet, Jean-Pierre, Gottesman, Michael M., Gribnau, Joost, Wessels, Lodewyk, Linn, Sabine C., Jonkers, Jos, Borst, Piet
Wydane 2012